Pemigatinib for previously treated, locally advanced or metastatic cholangiocarcinoma: a multicentre, open-label, phase 2 study
Published Online: 2020-05-?
Journal: The Lancet Oncology•Publisher: Elsevier BV
Authors: Adrian G Murphy•Andrew S Paulson•Antoine Hollebecque•Arndt Vogel•Christine F Lihou•Daniel V Catenacci•David Gallinson•Davide Melisi•Do-Youn Oh•Efrat Dotan•Eric Van Cutsem•Ghassan K Abou-Alfa•Gina Vaccaro•Huiling Zhen•Luis Féliz•Mitesh J Borad•Raed Al-Rajabi•Tao Ji•Vaibhav Sahai